PCA3 and prostate carcinoma: We have demonstrated that tumor cells transfer (mutant) RNA into blood platelets in vitro and in vivo, and showed that blood platelets isolated from glioma and prostate cancer patients contain the cancer-associated RNA biomarkers EGFRvIII and PCA3, respectively.